[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Saturday, 28 February, 2004, 11:58 GMT
Viagra 'not effective on women'
Couple kissing
Pfizer said tests were inconclusive
Clinical tests of the anti-impotency drug Viagra have failed to prove it helps women achieve sexual arousal.

Pharmaceutical giant Pfizer said it was "disappointed" the eight-year-long study showed Viagra is not useful in treating female sexual disorders.

It said it will not be seeking approval from drug regulators in the US to make the drug available to women.

Viagra is one of most popular drugs in the world for the treatment of erectile dysfunction among men.


Pfizer said its scientists carried out tests on about 3,000 women since 1996.

This is the nature of drug development
Karen Katen, Pfizer Global Pharmaceuticals president
It said some of the women were issued with placebos and some with Viagra.

While the Viagra was found to be harmless, its degree of effectiveness could not be conclusively determined.

"While we were disappointed that the FSAD [female sexual arousal disorder] programme was not more successful, this is the nature of drug development," said Pfizer Global Pharmaceuticals president Karen Katen.

The company said it is studying other forms of treatment for FSAD.

Since Viagra was introduced in 1998,more than 23 million men have been prescribed the drug worldwide, Pfizer says.

Annual sales are worth nearly $2bn.

Pupils took Viagra in lunch break
22 Oct 03  |  Hampshire/Dorset
Viagra rival from African tree
04 Sep 03  |  Health
Viagra rival approved in US
20 Aug 03  |  Business
Viagra could go over-the-counter
08 Feb 02  |  Health
Sex drug could help women
12 Feb 03  |  Health

The BBC is not responsible for the content of external internet sites


News Front Page | Africa | Americas | Asia-Pacific | Europe | Middle East | South Asia
UK | Business | Entertainment | Science/Nature | Technology | Health
Have Your Say | In Pictures | Week at a Glance | Country Profiles | In Depth | Programmes
Americas Africa Europe Middle East South Asia Asia Pacific